Astellas Pharma buys OSI for $4 billion
- May 17, 2010
Astellas Pharma Inc., Japan’s No. 2 drug maker, said Monday it will buy U.S. cancer drug company OSI Pharmaceuticals Inc. for $4 billion in cash in a bid to expand its ... Read More
Astellas Pharma Inc., Japan’s No. 2 drug maker, said Monday it will buy U.S. cancer drug company OSI Pharmaceuticals Inc. for $4 billion in cash in a bid to expand its ... Read More
France-based Areva, best known for its work in nuclear power, said on Monday it has acquired concentrating solar-power start-up Ausra for an undisclosed price. The acquisition will expand Areva’s business interests ... Read More
Billionaire investor Carl Icahn is backing a startup company that would build trains to run on President Barack Obama’s high-speed rail network, challenging international manufacturers that dominate the market, the company ... Read More
Ametek, which makes electric motors, battery chargers and products for aerospace, defense and other industries, said Tuesday it has acquired privately held Technical Services for Electronics for an undisclosed amount, The ... Read More
Ameren Corp. said Monday it created a new subsidiary dedicated to electric transmission infrastructure investment and identified $3 billion in potential projects. The new company, Ameren Transmission Co. (ATX), will build ... Read More
Alpla Inc., a privately held $3 billion manufacturer of plastic packaging solutions, has purchased an 83,485 square-foot industrial property at 9 Cermak Blvd. in St. Peters, Mo. Austrian-based Alpla is a ... Read More
Akermin Inc. said Tuesday it raised $10 million in its Series B financing round and will use the new funds to develop and bring to market its carbon-capture system for power ... Read More
Alliant Tech Systems announced Monday that it received $372 million in orders from the U.S. Army Contracting Command in Rock Island, Ill., to be produced at the Lake City Army Ammunition ... Read More
American International Group will sell a second overseas life and health insurance unit for $15.5 billion to MetLife Inc. in an ongoing bid to repay billions in government aid. It was ... Read More
Abbott Laboratories announced late Tuesday that it had agreed to buy Facet Biotech for a net price of $450 million in cash, in a move aimed at expanding its drug pipeline, ... Read More